For phenotypic characterization of SARS-CoV-2-specific CD8+ T cells, we combined pMHC multimer analysis with a 13-parameter antibody panel (Table S8) and evaluated the phenotype of the SARS-CoV-2-reactive T cell populations in COVID-19 patients and healthy donors. This evidence concerns the gene CD8A and COVID-19.